|
Re: M&A in industry- Cardinal Resources
|
6
|
Copper Fox Metals Inc.
|
Jun 18, 2020 04:05PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 09:56AM
|
|
Re: Elmer
|
6
|
Copper Fox Metals Inc.
|
Feb 20, 2023 06:43PM
|
|
The Pitfalls of Greed
|
6
|
Copper Fox Metals Inc.
|
Mar 03, 2021 10:56AM
|
|
Re: Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2).
|
6
|
Resverlogix Corp.
|
Aug 24, 2021 02:53PM
|
|
Re: New insights from this study -- Questions for scientists.
|
6
|
Resverlogix Corp.
|
Jun 08, 2022 01:17PM
|
|
Re: Copper Fox Announces Re-pricing of $1,800,000 Non-brokered Private Placement
|
6
|
Copper Fox Metals Inc.
|
Mar 11, 2020 09:50AM
|
|
Re: Discount rate
|
6
|
Copper Fox Metals Inc.
|
Apr 08, 2024 01:51PM
|
|
Re: Silent SH
|
6
|
Copper Fox Metals Inc.
|
Sep 16, 2021 02:56PM
|
|
Re: Program results
|
6
|
Copper Fox Metals Inc.
|
Apr 04, 2024 12:11PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
6
|
Resverlogix Corp.
|
Feb 05, 2021 08:49PM
|
|
Re: Was just reading the hepa release again from June 29th
|
6
|
Resverlogix Corp.
|
Jul 14, 2020 06:02PM
|
|
Re: Letter to Teck -- Stop the hostile and costly SCJV partner starvation insanity
|
6
|
Copper Fox Metals Inc.
|
May 18, 2023 05:11PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 05:12PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 08:58AM
|
|
Re: news
|
6
|
Copper Fox Metals Inc.
|
Mar 24, 2021 01:06PM
|
|
Re: Feb. 29th
|
6
|
Copper Fox Metals Inc.
|
Apr 04, 2024 12:47PM
|
|
Re: Copper Fox - Big on Promises Short on Delivery
|
6
|
Copper Fox Metals Inc.
|
Aug 21, 2020 09:54AM
|
|
Re: Re Colin's reply
|
6
|
Copper Fox Metals Inc.
|
Oct 17, 2022 01:44PM
|
|
Re: Teck Seeking Sale of Stake in $8 Billon Coal Business
|
6
|
Copper Fox Metals Inc.
|
Feb 22, 2022 07:48PM
|
